Department of Gastroenterology, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China, 256603.
Department of Interventional Medicine and Vascular, Binzhou Medical University Hospital, No. 661 Huanghe 2nd Road, Binzhou, 256603, Shandong Province, People's Republic of China.
BMC Gastroenterol. 2021 Dec 14;21(1):465. doi: 10.1186/s12876-021-02046-3.
Whether different embolic particles with comparable diameter lead to similar beneficial effects in endovascular embolization of hemorrhoidal disease remains to be established. We sought to evaluate the efficacy and safety of different types of agents for superior rectal arterial embolization (SRAE) in patients with bleeding hemorrhoids.
Patients with recurrent episodes of internal hemorrhoidal bleeding and chronic anemia treated by SRAE in three tertiary hospitals between March 2017 and June 2020 were retrospectively evaluated. The patients were divided into two study groups based on the embolic materials: embolization with coils (2-3 mm) + gelfoam particles at 350-560 μm (Group A, n = 23), embolization with coils (2-3 mm) + microparticles at 300-500 μm (Group B, n = 18). The technical success, preliminary clinical efficacy (percentage of patients without hematochezia), postoperative complications and short-term follow-up outcomes were analysed.
A total of 41 patients (27 males) with symptomatic hemorrhoids were included in the study, mean age was 47 ± 12 years (range 25-72). 39% (16) patients with grade II hemorrhoids while 61% (25) patients with grade III. The technical success rate of the embolization procedure was 100%, and the preliminary clinical efficacy (87.0% vs 88.9%) showed no significant difference between the 2 groups (p = 0.098). No patients reported post-procedural and short-term serious complications, such as infection, intestinal ischemia or massive hemorrhage during the follow-up period (range 6-15 months).
Both gelfoam particles and microparticles with comparable diameter in the endovascular treatment of hemorrhoidal bleeding demonstrated similarly good short-term efficacy and safety profile.
在直肠上动脉栓塞术(SRAE)治疗痔出血中,不同直径的栓塞颗粒是否具有相似的有益效果仍有待确定。我们旨在评估三种不同栓塞剂用于治疗出血性痔的疗效和安全性。
回顾性分析 2017 年 3 月至 2020 年 6 月期间在三家三级医院接受 SRAE 治疗的复发性内痔出血和慢性贫血患者。根据栓塞材料将患者分为两组:2-3mm 微弹簧圈+350-560μm 明胶海绵颗粒栓塞组(A 组,n=23)和 2-3mm 微弹簧圈+300-500μm 微球栓塞组(B 组,n=18)。分析技术成功率、初步临床疗效(无血便患者比例)、术后并发症和短期随访结果。
共纳入 41 例(27 例男性)有症状性痔患者,平均年龄为 47±12 岁(范围 25-72)。39%(16 例)患者为Ⅱ度痔,61%(25 例)患者为Ⅲ度痔。栓塞术的技术成功率为 100%,两组间初步临床疗效(87.0% vs 88.9%)无显著差异(p=0.098)。在随访期间(6-15 个月),无患者报告术后和短期严重并发症,如感染、肠缺血或大出血。
在治疗痔出血的血管内治疗中,明胶海绵颗粒和微球的直径相似,均具有良好的短期疗效和安全性。